Phase II Study of Grass Pollen Allergy Vaccine BM32 (Q63319662)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II Study of Grass Pollen Allergy Vaccine BM32 |
clinical trial |
Statements
Phase IIb Study on the Safety and Efficacy of BM32, a Recombinant Hypoallergenic Vaccine for Immunotherapy of Grass Pollen Allergy (English)
0 references
March 2012
0 references
December 2014
0 references
181
0 references
18 year
0 references
60 year
0 references